Hajek, Peter https://orcid.org/0000-0001-9160-4296
Przulj, Dunja https://orcid.org/0000-0003-1133-8835
Pesola, Francesca https://orcid.org/0000-0002-2054-7930
Griffiths, Chris https://orcid.org/0000-0001-7935-8694
Walton, Robert
McRobbie, Hayden https://orcid.org/0000-0002-7777-1845
Coleman, Tim https://orcid.org/0000-0002-7303-4805
Lewis, Sarah https://orcid.org/0000-0001-5308-6619
Whitemore, Rachel
Clark, Miranda https://orcid.org/0000-0002-6179-046X
Ussher, Michael
Sinclair, Lesley https://orcid.org/0000-0002-2210-8181
Seager, Emily
Cooper, Sue
Bauld, Linda https://orcid.org/0000-0001-7411-4260
Naughton, Felix
Sasieni, Peter https://orcid.org/0000-0003-1509-8744
Manyonda, Isaac
Myers Smith, Katie https://orcid.org/0000-0003-1837-3924
Funding for this research was provided by:
DH | NIHR | Health Technology Assessment Programme (12/57/85, 12/57/85, 12/57/85, 12/57/85, 12/57/85, 12/57/85, 12/57/85, 12/57/85, 12/57/85, 12/57/85, 12/57/85, 12/57/85, 12/57/85, 12/57/85, 12/57/85)
Article History
Received: 6 September 2021
Accepted: 31 March 2022
First Online: 16 May 2022
Change Date: 7 November 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41591-022-02099-1
Competing interests
: P.H. provided consultancy to and received research funding from Pfizer. D.P. received research funding from Pfizer. H.M. has received honoraria for speaking at smoking cessation educational events and sitting on an advisory board organized by Pfizer. All other authors have no competing interests.